0001127602-22-019721.txt : 20220725
0001127602-22-019721.hdr.sgml : 20220725
20220725142402
ACCESSION NUMBER: 0001127602-22-019721
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20220721
FILED AS OF DATE: 20220725
DATE AS OF CHANGE: 20220725
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: NABEL ELIZABETH G
CENTRAL INDEX KEY: 0001619929
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-39348
FILM NUMBER: 221102837
MAIL ADDRESS:
STREET 1: BRIGHAM AND WOMEN'S HOSPITAL
STREET 2: 75 FRANCIS ST
CITY: BOSTON
STATE: MA
ZIP: 02115
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Accolade, Inc.
CENTRAL INDEX KEY: 0001481646
STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-BUSINESS SERVICES, NEC [7389]
IRS NUMBER: 432117836
STATE OF INCORPORATION: DE
FISCAL YEAR END: 0228
BUSINESS ADDRESS:
STREET 1: 660 W. GERMANTOWN PIKE SUITE 500
CITY: PLYMOUTH MEETING
STATE: PA
ZIP: 19462
BUSINESS PHONE: 347-574-3820
MAIL ADDRESS:
STREET 1: 660 W. GERMANTOWN PIKE SUITE 500
CITY: PLYMOUTH MEETING
STATE: PA
ZIP: 19462
FORMER COMPANY:
FORMER CONFORMED NAME: Accolade LLC
DATE OF NAME CHANGE: 20100121
4
1
form4.xml
PRIMARY DOCUMENT
X0306
4
2022-07-21
0001481646
Accolade, Inc.
ACCD
0001619929
NABEL ELIZABETH G
C/O ACCOLADE, INC.
1201 THIRD AVENUE, SUITE 1700
SEATTLE
WA
98101
1
Common Stock
2022-07-21
4
M
0
2659
A
3005
D
Restricted Stock Units
2022-07-21
4
M
0
2659
D
Common Stock
2659
0
D
Each Restricted Stock Unit ("RSU") converted into one share of the Issuer's common stock.
Each RSU represents the contingent right to receive one share of Common Stock upon vesting of the RSU.
The shares subject to the RSU will vest on the earlier of (i) the date of the following annual meeting of the Issuer's stockholders (or the date immediately prior to the next annual meeting of the Issuer's stockholders if the Reporting Person's service as a director ends at such meeting due to the Reporting Person's failure to be re-elected or the director not standing for re-election) or (ii) the one year anniversary measured from the date of grant, each subject to continued service as a director through each applicable vesting date.
/s/ Richard Eskew, Attorney-in-Fact
2022-07-25